WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (CRL) today announced the initial cohort of its Charles River Incubator Program (CIP). Launched in December 2024, ...
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results